Voya Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,422
Closed -$626K 495
2021
Q1
$626K Sell
18,422
-11,256
-38% -$401K 0.02% 378
2020
Q4
$1.04M Buy
29,678
+1,514
+5% +$52.3K 0.04% 263
2020
Q3
$989K Buy
28,164
+898
+3% +$29.9K 0.05% 256
2020
Q2
$894K Buy
27,266
+322
+1% +$10.3K 0.05% 266
2020
Q1
$811K Buy
26,944
+2,022
+8% +$60.2K 0.04% 263
2019
Q4
$719K Buy
24,922
+12,226
+96% +$339K 0.04% 329
2019
Q3
$328K Buy
12,696
+182
+1% +$4.6K 0.02% 466
2019
Q2
$318K Sell
12,514
-1,556
-11% -$38.5K 0.02% 475
2019
Q1
$366K Buy
14,070
+662
+5% +$16.3K 0.02% 436
2018
Q4
$307K Buy
13,408
+240
+2% +$5.33K 0.02% 427
2018
Q3
$314K Sell
13,168
-852
-6% -$20.8K 0.02% 467
2018
Q2
$319K Sell
14,020
-1,562
-10% -$37.1K 0.02% 425
2018
Q1
$383K Sell
15,582
-454
-3% -$11.9K 0.03% 370
2017
Q4
$431K Sell
16,036
-144
-0.9% -$3.66K 0.03% 348
2017
Q3
$389K Sell
16,180
-8,206
-34% -$185K 0.03% 348
2017
Q2
$517K Sell
24,386
-1,302
-5% -$26.3K 0.04% 289
2017
Q1
$439K Buy
25,688
+1,202
+5% +$20.9K 0.03% 313
2016
Q4
$439K Buy
24,486
+7,342
+43% +$133K 0.04% 294
2016
Q3
$358K Buy
17,144
+746
+5% +$18.5K 0.04% 296
2016
Q2
$435K Buy
16,398
+18
+0.1% +$494 0.05% 235
2016
Q1
$444K Buy
16,380
+500
+3% +$13.4K 0.06% 220
2015
Q4
$466K Sell
15,880
-14
-0.1% -$387 0.07% 207
2015
Q3
$425K Buy
15,894
+1,158
+8% +$32.8K 0.08% 193
2015
Q2
$403K Buy
14,736
+442
+3% +$12.4K 0.07% 190
2015
Q1
$391K Buy
+14,294
New +$329K 0.08% 206

Other funds holding NVO